These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 8651844

  • 1. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus.
    Ward MM, Pyun E, Studenski S.
    Arch Intern Med; 1996 Jun 24; 156(12):1337-44. PubMed ID: 8651844
    [Abstract] [Full Text] [Related]

  • 2. Hospital experience and mortality in patients with systemic lupus erythematosus: which patients benefit most from treatment at highly experienced hospitals?
    Ward MM.
    J Rheumatol; 2002 Jun 24; 29(6):1198-206. PubMed ID: 12064835
    [Abstract] [Full Text] [Related]

  • 3. Development and testing of a systemic lupus-specific risk adjustment index for in-hospital mortality.
    Ward MM.
    J Rheumatol; 2000 Jun 24; 27(6):1408-13. PubMed ID: 10852262
    [Abstract] [Full Text] [Related]

  • 4. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus.
    Drenkard C, Villa AR, Alarcón-Segovia D, Pérez-Vázquez ME.
    J Rheumatol; 1994 Jun 24; 21(6):1067-72. PubMed ID: 7932417
    [Abstract] [Full Text] [Related]

  • 5. Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients.
    Rabbani MA, Habib HB, Islam M, Ahmad B, Majid S, Saeed W, Shah SM, Ahmad A.
    Lupus; 2009 Aug 24; 18(9):848-55. PubMed ID: 19578112
    [Abstract] [Full Text] [Related]

  • 6. Age associated clinical manifestations of systemic lupus erythematosus: a multivariate regression analysis.
    Ward MM, Studenski S.
    J Rheumatol; 1990 Apr 24; 17(4):476-81. PubMed ID: 2348426
    [Abstract] [Full Text] [Related]

  • 7. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus.
    Zonana-Nacach A, Yañez P, Jiménez-Balderas FJ, Camargo-Coronel A.
    Lupus; 2007 Apr 24; 16(12):997-1000. PubMed ID: 18042596
    [Abstract] [Full Text] [Related]

  • 8. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality.
    Abu-Shakra M, Urowitz MB, Gladman DD, Gough J.
    J Rheumatol; 1995 Jul 24; 22(7):1265-70. PubMed ID: 7562756
    [Abstract] [Full Text] [Related]

  • 9. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity.
    Cook RJ, Gladman DD, Pericak D, Urowitz MB.
    J Rheumatol; 2000 Aug 24; 27(8):1892-5. PubMed ID: 10955329
    [Abstract] [Full Text] [Related]

  • 10. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.
    Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Mejía JC, Aydintug AO, Chwalinska-Sadowska H, de Ramón E, Fernández-Nebro A, Galeazzi M, Valen M, Mathieu A, Houssiau F, Caro N, Alba P, Ramos-Casals M, Ingelmo M, Hughes GR, European Working Party on Systemic Lupus Erythematosus.
    Medicine (Baltimore); 2003 Sep 24; 82(5):299-308. PubMed ID: 14530779
    [Abstract] [Full Text] [Related]

  • 11. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
    Mok CC, Lau CS, Wong RW.
    J Rheumatol; 2001 Apr 24; 28(4):766-71. PubMed ID: 11327248
    [Abstract] [Full Text] [Related]

  • 12. The clinical manifestations and survival of systemic lupus erythematosus patients in Turkey: report from two centers.
    Pamuk ON, Akbay FG, Dönmez S, Yilmaz N, Calayir GB, Yavuz S.
    Lupus; 2013 Nov 24; 22(13):1416-24. PubMed ID: 23929639
    [Abstract] [Full Text] [Related]

  • 13. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study.
    Kwok SK, Ju JH, Cho CS, Kim HY, Park SH.
    Lupus; 2009 Jan 24; 18(1):16-21. PubMed ID: 19074164
    [Abstract] [Full Text] [Related]

  • 14. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.
    Ruiz-Irastorza G, Egurbide MV, Ugalde J, Aguirre C.
    Arch Intern Med; 2004 Jan 12; 164(1):77-82. PubMed ID: 14718326
    [Abstract] [Full Text] [Related]

  • 15. Systemic lupus erythematosus in the Fars Province of Iran.
    Nazarinia MA, Ghaffarpasand F, Shamsdin A, Karimi AA, Abbasi N, Amiri A.
    Lupus; 2008 Mar 12; 17(3):221-7. PubMed ID: 18372364
    [Abstract] [Full Text] [Related]

  • 16. Mortality patterns in Malaysian systemic lupus erythematosus patients.
    Yeap SS, Chow SK, Manivasagar M, Veerapen K, Wang F.
    Med J Malaysia; 2001 Sep 12; 56(3):308-12. PubMed ID: 11732075
    [Abstract] [Full Text] [Related]

  • 17. Familiality and co-occurrence of clinical features of systemic lupus erythematosus.
    Tsao BP, Grossman JM, Riemekasten G, Strong N, Kalsi J, Wallace DJ, Chen CJ, Lau CS, Ginzler EM, Goldstein R, Kalunian KC, Harley JB, Arnett FC, Hahn BH, Cantor RM.
    Arthritis Rheum; 2002 Oct 12; 46(10):2678-85. PubMed ID: 12384927
    [Abstract] [Full Text] [Related]

  • 18. Predictors of mortality in diffuse alveolar haemorrhage associated with systemic lupus erythematosus.
    Martínez-Martínez MU, Abud-Mendoza C.
    Lupus; 2011 May 12; 20(6):568-74. PubMed ID: 21558137
    [Abstract] [Full Text] [Related]

  • 19. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death.
    Abu-Shakra M, Urowitz MB, Gladman DD, Gough J.
    J Rheumatol; 1995 Jul 12; 22(7):1259-64. PubMed ID: 7562755
    [Abstract] [Full Text] [Related]

  • 20. Mortality in Malaysians with systemic lupus erythematosus.
    Paton NI, Cheong I, Kong NC, Segasothy M.
    Med J Malaysia; 1996 Dec 12; 51(4):437-41. PubMed ID: 10968030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.